首页> 外文期刊>Journal of the European Academy of Dermatology and Venereology: JEADV >Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group
【24h】

Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group

机译:基于“光化学场损伤”概念的MAL霜日光光动力疗法用于大规模光损伤皮肤:国际专家组的建议

获取原文
获取原文并翻译 | 示例
           

摘要

Conventional PDT (c-PDT) is a widely used and approved non-invasive treatment for actinic keratosis (AK). Recent clinical, histological and immunohistochemical observations have shown that c-PDT with methyl aminolevulinate (MAL) may also partially reverse the signs of photodamage. However, pain and the need for special light source equipment are limiting factors for its use, especially in the treatment of large areas. More recently, daylight PDT (DL-PDT) has been shown to be similar to c-PDT in the treatment of AK, nearly painless and more convenient to perform. To establish consensus on recommendations for the use of MAL DL-PDT in patients with large-scale photodamaged skin. The expert group was comprised of eight dermatologists. Consensus was developed based on the personal experience of the experts in c-PDT and DL-PDT, and results of an extensive literature review. MAL DL-PDT for large areas of photodamaged skin was evaluated and recommendations based on broad clinical experience were provided. As supported by evidence-based data from multicentre studies conducted in Australia and Europe, the authors defined the concept of 'actinic field damage' which refers to photodamage associated with actinic epidermal dysplasia, and provide comprehensive guidelines for the optimal use of DL-PDT in the treatment of actinic field damage. The authors concluded that MAL DL-PDT has a similar efficacy to c-PDT at 3-month (lesion complete response rate of 89% vs. 93% in the Australian study and 70% vs. 74% in the European study (95% C. I. = [-6.8; -0.3] and [-9.5; 2.4] respectively) and 6-month follow-ups (97% maintenance of complete lesion response) in the treatment of AKs. The authors agree that DL-PDT is not only efficacious but also nearly pain-free and easy to perform, and therefore results in high patient acceptance especially for the treatment of areas of actinic field damage.
机译:常规PDT(c-PDT)是一种广泛使用并被认可的用于光化性角化病(AK)的非侵入性治疗方法。最近的临床,组织学和免疫组织化学观察表明,含氨基乙酰丙酸甲酯(MAL)的c-PDT也可能部分逆转光损伤的迹象。但是,疼痛和对特殊光源设备的需求是其使用的限制因素,特别是在大面积的治疗中。最近,已证明日光PDT(DL-PDT)在AK的治疗中与c-PDT相似,几乎无痛且执行起来更方便。就在大规模光损伤皮肤患者中使用MAL DL-PDT的建议建立共识。专家组由八名皮肤科医生组成。共识是根据c-PDT和DL-PDT专家的个人经验以及广泛文献回顾的结果而制定的。对大面积光损伤皮肤的MAL DL-PDT进行了评估,并根据广泛的临床经验提供了建议。在澳大利亚和欧洲进行的多中心研究的循证数据的支持下,作者定义了“光化场损伤”的概念,这是指与光化性表皮异型增生相关的光损伤,并提供了在DL-PDT中最佳使用的综合指南。光化场损伤的治疗。作者得出的结论是,MAL DL-PDT在3个月时的疗效与c-PDT相似(澳大利亚研究的病灶完全缓解率分别为89%和93%,欧洲研究的病灶完全缓解率分别为70%和74%(95% CI分别为[-6.8; -0.3]和[-9.5; 2.4])和6个月的随访(维持病灶完全缓解率97%),作者同意DL-PDT不仅是有效,但几乎无痛且易于执行,因此特别是在治疗光化性视野损伤的领域中获得了较高的患者接受度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号